Cargando…

Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease

Insulin resistance from chronic kidney disease (CKD) stimulates muscle protein wasting but mechanisms causing this resistance are controversial. To help resolve this, we used microarray analyses to identify initiators of insulin resistance in the muscles of mice with CKD, glucose intolerance and ins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Sandhya S., Dong, Yanjun, Zhang, Liping, Mitch, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777429/ https://www.ncbi.nlm.nih.gov/pubmed/23515050 http://dx.doi.org/10.1038/ki.2013.97

Ejemplares similares

Molecular Mechanisms of Insulin Resistance in Chronic Kidney Disease
por: Thomas, Sandhya S., et al.
Publicado: (2015)

Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact
por: Rajan, Vik R., et al.
Publicado: (2008)

Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues
por: Dong, Jiangling, et al.
Publicado: (2015)

Long‐noncoding RNA Atrolnc‐1 promotes muscle wasting in mice with chronic kidney disease
por: Sun, Lijing, et al.
Publicado: (2018)

The impact of senescence on muscle wasting in chronic kidney disease
por: Huang, Ying, et al.
Publicado: (2022)

Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease
por: Wang, Dong-Tao, et al.
Publicado: (2015)

Suppression of muscle wasting by the plant‐derived compound ursolic acid in a model of chronic kidney disease
por: Yu, Rizhen, et al.
Publicado: (2016)

TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease
por: Gu, Lijie, et al.
Publicado: (2022)

Insulin Resistance and Muscle Metabolism in Chronic Kidney Disease
por: Bailey, James L.
Publicado: (2013)

The Insulin Receptor Mediates Insulin’s Early Plasma Clearance by Liver, Muscle, and Kidney
por: Meijer, Rick I., et al.
Publicado: (2021)

Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease
por: Zhang, Yue-yue, et al.
Publicado: (2018)

Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk
por: Wu, Jiao, et al.
Publicado: (2019)

Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut‐renal muscle axis
por: Pei, Tingting, et al.
Publicado: (2022)

Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications—A Narrative Review
por: Cheng, Tsai-Chin, et al.
Publicado: (2022)

Factors contributing to muscle wasting and dysfunction in COPD patients
por: Wüst, Rob CI, et al.
Publicado: (2007)

Muscle wasting in ageing and chronic illness
por: Ebner, Nicole, et al.
Publicado: (2015)

Erratum to: Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Estrogen receptor-α in female skeletal muscle is not required for regulation of muscle insulin sensitivity and mitochondrial regulation
por: Iñigo, Melissa R., et al.
Publicado: (2019)

Retention of acetylcarnitine in chronic kidney disease causes insulin resistance in skeletal muscle
por: Miyamoto, Yasunori, et al.
Publicado: (2016)

Mitochondrial dysfunction in insulin resistance: differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells
por: Yang, Chenjing, et al.
Publicado: (2012)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Skeletal muscle wasting in chronic heart failure
por: Suzuki, Tsuyoshi, et al.
Publicado: (2018)

Low protein diet supplemented with ketoacids on muscle wasting in chronic kidney disease: A clinical trial
por: Zhang, Yueyue, et al.
Publicado: (2022)

Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
por: Groothof, Dion, et al.
Publicado: (2023)

Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016)

GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting
por: Culver, Alexander, et al.
Publicado: (2023)

Diets for patients with chronic kidney disease, should we reconsider?
por: Mitch, William E., et al.
Publicado: (2016)

Tumor necrosis factor-α and muscle wasting: a cellular perspective
por: Reid, Michael B, et al.
Publicado: (2001)

Protein-Energy Wasting and Mortality in Chronic Kidney Disease
por: Bonanni, Alice, et al.
Publicado: (2011)

Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia
por: Mak, Robert H., et al.
Publicado: (2022)

Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
por: Renna, Laura Valentina, et al.
Publicado: (2017)

Insulin receptors in the kidneys in health and disease
por: Singh, Sarojini, et al.
Publicado: (2019)

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis
por: Garibotto, Giacomo, et al.
Publicado: (2015)

Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers
por: Koppe, Laetitia, et al.
Publicado: (2019)

Preventing muscle wasting: pro‐insulin C‐peptide prevents loss in muscle mass in streptozotocin‐diabetic rats
por: Maurotti, Samantha, et al.
Publicado: (2023)

Erratum to: Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016)

Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia
por: Zhang, Zhige, et al.
Publicado: (2023)

Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients
por: Gómez-García, Erika F., et al.
Publicado: (2022)

Muscle Wasting in Chronic Obstructive Pulmonary Disease: Not Enough Autophagy?
por: Leduc-Gaudet, Jean-Philippe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldrps4j97v4pq2if1plhmv0o58